A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease

International Review of Cell and Molecular Biology

Volumn 334, Issue , 2018, Pages 99-175

  Weiss, Cary N ^a   Ito, Keisuke ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

Author keywords

Cancer; Hematopoiesis; Leukemia; MicroRNA; MiRNA; MiRNA therapeutics

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 155; MICRORNA 164A; MICRORNA 181; MICRORNA 223; NUCLEIC ACID; UNCLASSIFIED DRUG;

CELL DIFFERENTIATION; GENE MUTATION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; HUMAN; HYPOTHESIS; LEUKEMIA; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHYSIOLOGICAL PROCESS; PROGNOSIS; RNA PROCESSING; STEM CELL; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; GENETICS; METABOLISM;

ANIMALS; HEMATOLOGIC DISEASES; HEMATOPOIESIS; HUMANS; MICRORNAS; MODELS, BIOLOGICAL;

EID: 85018644876     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2017.03.007     Document Type: Chapter

References (333)

1. Abdel-Wahab, O., Mullally, A., Hedvat, C., Garcia-Manero, G., Patel, J., Wadleigh, M., Malinge, S., Yao, J., Kilpivaara, O., Bhat, R., Huberman, K., Thomas, S., Dolgalev, I., Heguy, A., Paietta, E., Le Beau, M.M., Beran, M., Tallman, M.S., Ebert, B.L., Kantarjian, H.M., Stone, R.M., Gilliland, D.G., Crispino, J.D., Levine, R.L., Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 114 (2009), 144–147.
2. Agarwal, V., Bell, G.W., Nam, J.W., Bartel, D.P., Predicting effective microRNA target sites in mammalian mRNAs. eLife, 4, 2015, e05005.
3. Akbari Moqadam, F., Pieters, R., Den Boer, M.L., The hunting of targets: challenge in miRNA research. Leukemia 27 (2013), 16–23.
4. Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E.S., Busini, V., Hossain, N., Bacallado, S.A., Nguyen, D.N., Fuller, J., Alvarez, R., Borodovsky, A., Borland, T., Constien, R., De Fougerolles, A., Dorkin, J.R., Narayanannair Jayaprakash, K., Jayaraman, M., John, M., Koteliansky, V., Manoharan, M., Nechev, L., Qin, J., Racie, T., Raitcheva, D., Rajeev, K.G., Sah, D.W., Soutschek, J., Toudjarska, I., Vornlocher, H.P., Zimmermann, T.S., Langer, R., Anderson, D.G., A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26 (2008), 561–569.
5. Ala, U., Karreth, F.A., Bosia, C., Pagnani, A., Taulli, R., Leopold, V., Tay, Y., Provero, P., Zecchina, R., Pandolfi, P.P., Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc. Natl. Acad. Sci. U.S.A. 110 (2013), 7154–7159.
6. Ambros, V., Horvitz, H.R., Heterochronic mutants of the nematode Caenorhabditis elegans. Science 226 (1984), 409–416.
7. Ambros, V., Lee, R.C., Lavanway, A., Williams, P.T., Jewell, D., MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr. Biol. 13 (2003), 807–818.
8. Arasu, P., Wightman, B., Ruvkun, G., Temporal regulation of lin-14 by the antagonistic action of two other heterochronic genes, lin-4 and lin-28. Genes Dev. 5 (1991), 1825–1833.
9. Aravin, A.A., Lagos-Quintana, M., Yalcin, A., Zavolan, M., Marks, D., Snyder, B., Gaasterland, T., Meyer, J., Tuschl, T., The small RNA profile during Drosophila melanogaster development. Dev. Cell 5 (2003), 337–350.
10. Aravin, A., Gaidatzis, D., Pfeffer, S., Lagos-Quintana, M., Landgraf, P., Iovino, N., Morris, P., Brownstein, M.J., Kuramochi-Miyagawa, S., Nakano, T., Chien, M., Russo, J.J., Ju, J., Sheridan, R., Sander, C., Zavolan, M., Tuschl, T., A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442 (2006), 203–207.
11. Arvey, A., Larsson, E., Sander, C., Leslie, C.S., Marks, D.S., Target mRNA abundance dilutes microRNA and siRNA activity. Mol. Syst. Biol., 6, 2010, 363.
12. Avecilla, S.T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D.K., Dias, S., Zhang, F., Hartman, T.E., Hackett, N.R., Crystal, R.G., Witte, L., Hicklin, D.J., Bohlen, P., Eaton, D., Lyden, D., De Sauvage, F., Rafii, S., Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat. Med. 10 (2004), 64–71.
13. Bartel, D.P., MicroRNAs: target recognition and regulatory functions. Cell 136 (2009), 215–233.
14. Bazzini, A.A., Lee, M.T., Giraldez, A.J., Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 336 (2012), 233–237.
15. Behm-Ansmant, I., Rehwinkel, J., Doerks, T., Stark, A., Bork, P., Izaurralde, E., mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes Dev. 20 (2006), 1885–1898.
16. Berezikov, E., Chung, W.J., Willis, J., Cuppen, E., Lai, E.C., Mammalian mirtron genes. Mol. Cell 28 (2007), 328–336.
17. Bernardo, B.C., Charchar, F.J., Lin, R.C., Mcmullen, J.R., A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart Lung Circ. 21 (2012), 131–142.
18. Betel, D., Koppal, A., Agius, P., Sander, C., Leslie, C., Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11, 2010, R90.
19. Bhagat, T.D., Zhou, L., Sokol, L., Kessel, R., Caceres, G., Gundabolu, K., Tamari, R., Gordon, S., Mantzaris, I., Jodlowski, T., Yu, Y., Jing, X., Polineni, R., Bhatia, K., Pellagatti, A., Boultwood, J., Kambhampati, S., Steidl, U., Stein, C., Ju, W., Liu, G., Kenny, P., List, A., Bitzer, M., Verma, A., miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling. Blood 121 (2013), 2875–2881.
20. Bissels, U., Wild, S., Tomiuk, S., Hafner, M., Scheel, H., Mihailovic, A., Choi, Y.H., Tuschl, T., Bosio, A., Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133 + and CD34 + hematopoietic stem and progenitor cells. Stem Cells 29 (2011), 847–857.
21. Bohnsack, M.T., Czaplinski, K., Gorlich, D., Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10 (2004), 185–191.
22. Boldin, M.P., Taganov, K.D., Rao, D.S., Yang, L., Zhao, J.L., Kalwani, M., Garcia-Flores, Y., Luong, M., Devrekanli, A., Xu, J., Sun, G., Tay, J., Linsley, P.S., Baltimore, D., miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208 (2011), 1189–1201.
23. Borchert, G.M., Lanier, W., Davidson, B.L., RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13 (2006), 1097–1101.
24. Bosia, C., Pagnani, A., Zecchina, R., Modelling competing endogenous RNA networks. PLoS One, 8, 2013, e66609.
25. Bosson, A.D., Zamudio, J.R., Sharp, P.A., Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition. Mol. Cell 56 (2014), 347–359.
26. Bousquet, M., Quelen, C., Rosati, R., Mansat-De Mas, V., La Starza, R., Bastard, C., Lippert, E., Talmant, P., Lafage-Pochitaloff, M., Leroux, D., Gervais, C., Viguie, F., Lai, J.L., Terre, C., Beverlo, B., Sambani, C., Hagemeijer, A., Marynen, P., Delsol, G., Dastugue, N., Mecucci, C., Brousset, P., Myeloid cell differentiation arrest by miR-125b-1 in myelodysplastic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation. J. Exp. Med. 205 (2008), 2499–2506.
27. Bousquet, M., Harris, M.H., Zhou, B., Lodish, H.F., MicroRNA miR-125b causes leukemia. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 21558–21563.
28. Braun, J.E., Huntzinger, E., Fauser, M., Izaurralde, E., GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. Mol. Cell 44 (2011), 120–133.
29. Brennecke, J., Stark, A., Russell, R.B., Cohen, S.M., Principles of microRNA-target recognition. PLoS Biol., 3, 2005, e85.
30. Bueno, M.J., Perez De Castro, I., Gomez De Cedron, M., Santos, J., Calin, G.A., Cigudosa, J.C., Croce, C.M., Fernandez-Piqueras, J., Malumbres, M., Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13 (2008), 496–506.
31. Cai, X., Hagedorn, C.H., Cullen, B.R., Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 (2004), 1957–1966.
32. Calin, G.A., Dumitru, C.D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., Rassenti, L., Kipps, T., Negrini, M., Bullrich, F., Croce, C.M., Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 15524–15529.
33. Calin, G.A., Liu, C.G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C.D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., DELL'AQUILA, M.L., Alder, H., Rassenti, L., Kipps, T.J., Bullrich, F., Negrini, M., Croce, C.M., MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 11755–11760.
34. Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., Croce, C.M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 2999–3004.
35. Calin, G.A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S.E., Iorio, M.V., Visone, R., Sever, N.I., Fabbri, M., Iuliano, R., Palumbo, T., Pichiorri, F., Roldo, C., Garzon, R., Sevignani, C., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M., Croce, C.M., A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353 (2005), 1793–1801.
36. Capel, B., Swain, A., Nicolis, S., Hacker, A., Walter, M., Koopman, P., Goodfellow, P., Lovell-Badge, R., Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 73 (1993), 1019–1030.
37. Cazalla, D., Yario, T., Steitz, J.A., Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328 (2010), 1563–1566.
38. Cech, T.R., Steitz, J.A., The noncoding RNA revolution-trashing old rules to forge new ones. Cell 157 (2014), 77–94.
39. Chan, J.A., Krichevsky, A.M., Kosik, K.S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 65 (2005), 6029–6033.
40. Chekulaeva, M., Parker, R., Filipowicz, W., The GW/WG repeats of Drosophila GW182 function as effector motifs for miRNA-mediated repression. Nucleic Acids Res. 38 (2010), 6673–6683.
41. Chen, C.Z., Li, L., Lodish, H.F., Bartel, D.P., MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004), 83–86.
42. Chen, R.W., Bemis, L.T., Amato, C.M., Myint, H., Tran, H., Birks, D.K., Eckhardt, S.G., Robinson, W.A., Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. Blood 112 (2008), 822–829.
43. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., Li, Q., Li, X., Wang, W., Zhang, Y., Wang, J., Jiang, X., Xiang, Y., Xu, C., Zheng, P., Zhang, J., Li, R., Zhang, H., Shang, X., Gong, T., Ning, G., Wang, J., Zen, K., Zhang, J., Zhang, C.Y., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18 (2008), 997–1006.
44. Chi, S.W., Zang, J.B., Mele, A., Darnell, R.B., Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460 (2009), 479–486.
45. Chi, S.W., Hannon, G.J., Darnell, R.B., An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 19 (2012), 321–327.
46. Chim, C.S., Wong, K.Y., Leung, C.Y., Chung, L.P., Hui, P.K., Chan, S.Y., Yu, L., Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. J. Cell. Mol. Med. 15 (2011), 2760–2767.
47. Chiosea, S., Jelezcova, E., Chandran, U., Acquafondata, M., Mchale, T., Sobol, R.W., Dhir, R., Up-regulation of dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am. J. Pathol. 169 (2006), 1812–1820.
48. Chiu, S.C., Chung, H.Y., Cho, D.Y., Chan, T.M., Liu, M.C., Huang, H.M., Li, T.Y., Lin, J.Y., Chou, P.C., Fu, R.H., Yang, W.K., Harn, H.J., Lin, S.Z., Therapeutic potential of microRNA let-7: tumor suppression or impeding normal stemness. Cell Transplant. 23 (2014), 459–469.
49. Cimmino, A., Calin, G.A., Fabbri, M., Iorio, M.V., Ferracin, M., Shimizu, M., Wojcik, S.E., Aqeilan, R.I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C.G., Kipps, T.J., Negrini, M., Croce, C.M., miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 13944–13949.
50. Cipolla, G.A., A non-canonical landscape of the microRNA system. Front. Genet., 5, 2014, 337.
51. Copley, M.R., Babovic, S., Benz, C., Knapp, D.J., Beer, P.A., Kent, D.G., Wohrer, S., Treloar, D.Q., Day, C., Rowe, K., Mader, H., Kuchenbauer, F., Humphries, R.K., Eaves, C.J., The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15 (2013), 916–925.
52. Costinean, S., Sandhu, S.K., Pedersen, I.M., Tili, E., Trotta, R., Perrotti, D., Ciarlariello, D., Neviani, P., Harb, J., Kauffman, L.R., Shidham, A., Croce, C.M., Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114 (2009), 1374–1382.
53. Davis, B.N., Hilyard, A.C., Lagna, G., Hata, A., SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454 (2008), 56–61.
54. Davis, M.E., Zuckerman, J.E., Choi, C.H., Seligson, D., Tolcher, A., Alabi, C.A., Yen, Y., Heidel, J.D., Ribas, A., Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464 (2010), 1067–1070.
55. Dedes, K.J., Natrajan, R., Lambros, M.B., Geyer, F.C., Lopez-Garcia, M.A., Savage, K., Jones, R.L., Reis-Filho, J.S., Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur. J. Cancer 47 (2011), 138–150.
56. Denzler, R., Agarwal, V., Stefano, J., Bartel, D.P., Stoffel, M., Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell 54 (2014), 766–776.
57. Deshpande, A., Pastore, A., Deshpande, A.J., Zimmermann, Y., Hutter, G., Weinkauf, M., Buske, C., Hiddemann, W., Dreyling, M., 3’UTR mediated regulation of the cyclin D1 proto-oncogene. Cell Cycle 8 (2009), 3592–3600.
58. De Yebenes, V.G., Belver, L., Pisano, D.G., Gonzalez, S., Villasante, A., Croce, C., He, L., Ramiro, A.R., miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205 (2008), 2199–2206.
59. Didiano, D., Hobert, O., Perfect seed pairing is not a generally reliable predictor for miRNA-target interactions. Nat. Struct. Mol. Biol. 13 (2006), 849–851.
60. Dixon-Mciver, A., East, P., Mein, C.A., Cazier, J.B., Molloy, G., Chaplin, T., Andrew Lister, T., Young, B.D., Debernardi, S., Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One, 3, 2008, e2141.
61. Doench, J.G., Sharp, P.A., Specificity of microRNA target selection in translational repression. Genes Dev. 18 (2004), 504–511.
62. Dostie, J., Mourelatos, Z., Yang, M., Sharma, A., Dreyfuss, G., Numerous microRNPs in neuronal cells containing novel microRNAs. RNA 9 (2003), 180–186.
63. Ecker, J.R., Davis, R.W., Inhibition of gene expression in plant cells by expression of antisense RNA. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 5372–5376.
64. Eichhorn, S.W., Guo, H., Mcgeary, S.E., Rodriguez-Mias, R.A., Shin, C., Baek, D., Hsu, S.H., Ghoshal, K., Villen, J., Bartel, D.P., mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues. Mol. Cell 56 (2014), 104–115.
65. Eis, P.S., Tam, W., Sun, L., Chadburn, A., Li, Z., Gomez, M.F., Lund, E., Dahlberg, J.E., Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 3627–3632.
66. Elkayam, E., Kuhn, C.D., Tocilj, A., Haase, A.D., Greene, E.M., Hannon, G.J., Joshua-TOR, L., The structure of human argonaute-2 in complex with miR-20a. Cell 150 (2012), 100–110.
67. Elmen, J., Lindow, M., Schutz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjarn, M., Hansen, H.F., Berger, U., Gullans, S., Kearney, P., Sarnow, P., Straarup, E.M., Kauppinen, S., LNA-mediated microRNA silencing in non-human primates. Nature 452 (2008), 896–899.
68. Elmen, J., Lindow, M., Silahtaroglu, A., Bak, M., Christensen, M., Lind-Thomsen, A., Hedtjarn, M., Hansen, J.B., Hansen, H.F., Straarup, E.M., Mccullagh, K., Kearney, P., Kauppinen, S., Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36 (2008), 1153–1162.
69. Eulalio, A., Rehwinkel, J., Stricker, M., Huntzinger, E., Yang, S.F., Doerks, T., Dorner, S., Bork, P., Boutros, M., Izaurralde, E., Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes Dev. 21 (2007), 2558–2570.
70. Eulalio, A., Huntzinger, E., Izaurralde, E., GW182 interaction with Argonaute is essential for miRNA-mediated translational repression and mRNA decay. Nat. Struct. Mol. Biol. 15 (2008), 346–353.
71. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., Volinia, S., Guler, G., Morrison, C.D., Chan, K.K., Marcucci, G., Calin, G.A., Huebner, K., Croce, C.M., MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 15805–15810.
72. Fabian, M.R., Sonenberg, N., The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19 (2012), 586–593.
73. Fabian, M.R., Mathonnet, G., Sundermeier, T., Mathys, H., Zipprich, J.T., Svitkin, Y.V., Rivas, F., Jinek, M., Wohlschlegel, J., Doudna, J.A., Chen, C.Y., Shyu, A.B., Yates, J.R. 3rd, Hannon, G.J., Filipowicz, W., Duchaine, T.F., Sonenberg, N., Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. Mol. Cell 35 (2009), 868–880.
74. Fabian, M.R., Cieplak, M.K., Frank, F., Morita, M., Green, J., Srikumar, T., Nagar, B., Yamamoto, T., Raught, B., Duchaine, T.F., Sonenberg, N., miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT. Nat. Struct. Mol. Biol. 18 (2011), 1211–1217.
75. Faller, M., Guo, F., MicroRNA biogenesis: there's more than one way to skin a cat. Biochim. Biophys. Acta 1779 (2008), 663–667.
76. Fang, L., Du, W.W., Yang, X., Chen, K., Ghanekar, A., Levy, G., Yang, W., Yee, A.J., Lu, W.Y., Xuan, J.W., Gao, Z., Xie, F., He, C., Deng, Z., Yang, B.B., Versican 3’-untranslated region (3’-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 27 (2013), 907–919.
77. Faruq, O., Vecchione, A., microRNA: diagnostic perspective. Front. Med. (Lausanne), 2, 2015, 51.
78. Fayyad-Kazan, H., Bitar, N., Najar, M., Lewalle, P., Fayyad-Kazan, M., Badran, R., Hamade, E., Daher, A., Hussein, N., Eldirani, R., Berri, F., Vanhamme, L., Burny, A., Martiat, P., Rouas, R., Badran, B., Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J. Transl. Med., 11, 2013, 31.
79. Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M.L., Nervi, C., Bozzoni, I., A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123 (2005), 819–831.
80. Fazi, F., Racanicchi, S., Zardo, G., Starnes, L.M., Mancini, M., Travaglini, L., Diverio, D., Ammatuna, E., Cimino, G., Lo-Coco, F., Grignani, F., Nervi, C., Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 12 (2007), 457–466.
81. Ferrajoli, A., Shanafelt, T.D., Ivan, C., Shimizu, M., Rabe, K.G., Nouraee, N., Ikuo, M., Ghosh, A.K., Lerner, S., Rassenti, L.Z., Xiao, L., Hu, J., Reuben, J.M., Calin, S., You, M.J., Manning, J.T., Wierda, W.G., Estrov, Z., O'Brien, S., Kipps, T.J., Keating, M.J., Kay, N.E., Calin, G.A., Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood 122 (2013), 1891–1899.
82. Figliuzzi, M., Marinari, E., De Martino, A., MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys. J. 104 (2013), 1203–1213.
83. Fire, A., Albertson, D., Harrison, S.W., Moerman, D.G., Production of antisense RNA leads to effective and specific inhibition of gene expression in C. elegans muscle. Development 113 (1991), 503–514.
84. Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., Mello, C.C., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 (1998), 806–811.
85. Foulkes, W.D., Bahubeshi, A., Hamel, N., Pasini, B., Asioli, S., Baynam, G., Choong, C.S., Charles, A., Frieder, R.P., Dishop, M.K., Graf, N., Ekim, M., Bouron-Dal Soglio, D., Arseneau, J., Young, R.H., Sabbaghian, N., Srivastava, A., Tischkowitz, M.D., Priest, J.R., Extending the phenotypes associated with DICER1 mutations. Hum. Mutat. 32 (2011), 1381–1384.
86. Foulkes, W.D., Priest, J.R., Duchaine, T.F., DICER1: mutations, microRNAs and mechanisms. Nat. Rev. Cancer 14 (2014), 662–672.
87. Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A., Lund, A.H., Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 283 (2008), 1026–1033.
88. Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19 (2009), 92–105.
89. Fukao, T., Fukuda, Y., Kiga, K., Sharif, J., Hino, K., Enomoto, Y., Kawamura, A., Nakamura, K., Takeuchi, T., Tanabe, M., An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129 (2007), 617–631.
90. Furuta, M., Kozaki, K.I., Tanaka, S., Arii, S., Imoto, I., Inazawa, J., miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31 (2010), 766–776.
91. Gagnon, K.T., Li, L., Chu, Y., Janowski, B.A., Corey, D.R., RNAi factors are present and active in human cell nuclei. Cell Rep. 6 (2014), 211–221.
92. Garzon, R., Pichiorri, F., Palumbo, T., Visentini, M., Aqeilan, R., Cimmino, A., Wang, H., Sun, H., Volinia, S., Alder, H., Calin, G.A., Liu, C.G., Andreeff, M., Croce, C.M., MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26 (2007), 4148–4157.
93. Garzon, R., Garofalo, M., Martelli, M.P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C.G., Schnittger, S., Haferlach, T., Liso, A., Diverio, D., Mancini, M., Meloni, G., Foa, R., Martelli, M.F., Mecucci, C., Croce, C.M., Falini, B., Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 3945–3950.
94. Garzon, R., Volinia, S., Liu, C.G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., Fabbri, M., Coombes, K., Alder, H., Nakamura, T., Flomenberg, N., Marcucci, G., Calin, G.A., Kornblau, S.M., Kantarjian, H., Bloomfield, C.D., Andreeff, M., Croce, C.M., MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111 (2008), 3183–3189.
95. Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C.E., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., Havelange, V., Volinia, S., Blum, W., Rush, L.J., Perrotti, D., Andreeff, M., Bloomfield, C.D., Byrd, J.C., Chan, K., Wu, L.C., Croce, C.M., Marcucci, G., MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113 (2009), 6411–6418.
96. Gauwerky, C.E., Huebner, K., Isobe, M., Nowell, P.C., Croce, C.M., Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 8867–8871.
97. Geary, R.S., Antisense oligonucleotide pharmacokinetics and metabolism. Expert Opin. Drug Metab. Toxicol. 5 (2009), 381–391.
98. Geary, R.S., Leeds, J.M., Fitchett, J., Burckin, T., Truong, L., Spainhour, C., Creek, M., Levin, A.A., Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression. Drug Metab. Dispos. 25 (1997), 1272–1281.
99. Gregory, R.I., Yan, K.P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., Shiekhattar, R., The Microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004), 235–240.
100. Griffiths-Jones, S., The microRNA Registry. Nucleic Acids Res. 32 (2004), D109–D111.
101. Griffiths-Jones, S., Grocock, R.J., Van Dongen, S., Bateman, A., Enright, A.J., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34 (2006), D140–D144.
102. Grishok, A., Pasquinelli, A.E., Conte, D., Li, N., Parrish, S., Ha, I., Baillie, D.L., Fire, A., Ruvkun, G., Mello, C.C., Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106 (2001), 23–34.
103. Guo, S., Kemphues, K.J., par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81 (1995), 611–620.
104. Guo, H., Ingolia, N.T., Weissman, J.S., Bartel, D.P., Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466 (2010), 835–840.
105. Guo, S., Lu, J., Schlanger, R., Zhang, H., Wang, J.Y., Fox, M.C., Purton, L.E., Fleming, H.H., Cobb, B., Merkenschlager, M., Golub, T.R., Scadden, D.T., MicroRNA miR-125a controls hematopoietic stem cell number. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 14229–14234.
106. Guo, J.U., Agarwal, V., Guo, H., Bartel, D.P., Expanded identification and characterization of mammalian circular RNAs. Genome Biol., 15, 2014, 409.
107. Ha, I., Wightman, B., Ruvkun, G., A bulged lin-4/lin-14 RNA duplex is sufficient for Caenorhabditis elegans lin-14 temporal gradient formation. Genes Dev. 10 (1996), 3041–3050.
108. Hafner, M., Landthaler, M., Burger, L., Khorshid, M., Hausser, J., Berninger, P., Rothballer, A., Ascano, M. Jr., Jungkamp, A.C., Munschauer, M., Ulrich, A., Wardle, G.S., Dewell, S., Zavolan, M., Tuschl, T., Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141 (2010), 129–141.
109. Hammond, S.M., Bernstein, E., Beach, D., Hannon, G.J., An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404 (2000), 293–296.
110. Han, J., Lee, Y., Yeom, K.H., Kim, Y.K., Jin, H., Kim, V.N., The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18 (2004), 3016–3027.
111. Han, J., Lee, Y., Yeom, K.H., Nam, J.W., Heo, I., Rhee, J.K., Sohn, S.Y., Cho, Y., Zhang, B.T., Kim, V.N., Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 125 (2006), 887–901.
112. Hansen, T.B., Jensen, T.I., Clausen, B.H., Bramsen, J.B., Finsen, B., Damgaard, C.K., Kjems, J., Natural RNA circles function as efficient microRNA sponges. Nature 495 (2013), 384–388.
113. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., Hammond, S.M., A microRNA polycistron as a potential human oncogene. Nature 435 (2005), 828–833.
114. Helwak, A., Kudla, G., Dudnakova, T., Tollervey, D., Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153 (2013), 654–665.
115. Hermeking, H., The miR-34 family in cancer and apoptosis. Cell Death Differ. 17 (2010), 193–199.
116. Hildebrandt-Eriksen, E.S., Aarup, V., Persson, R., Hansen, H.F., Munk, M.E., Orum, H., A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther. 22 (2012), 152–161.
117. Hill, D.A., Ivanovich, J., Priest, J.R., Gurnett, C.A., Dehner, L.P., Desruisseau, D., Jarzembowski, J.A., Wikenheiser-Brokamp, K.A., Suarez, B.K., Whelan, A.J., Williams, G., Bracamontes, D., Messinger, Y., Goodfellow, P.J., DICER1 mutations in familial pleuropulmonary blastoma. Science, 325, 2009, 965.
118. Hou, J., Wang, P., Lin, L., Liu, X., Ma, F., An, H., Wang, Z., Cao, X., MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J. Immunol. 183 (2009), 2150–2158.
119. Houbaviy, H.B., Murray, M.F., Sharp, P.A., Embryonic stem cell-specific MicroRNAs. Dev. Cell 5 (2003), 351–358.
120. Hu, H., Li, Y., Gu, J., Zhu, X., Dong, D., Yao, J., Lin, C., Fei, J., Antisense oligonucleotide against miR-21 inhibits migration and induces apoptosis in leukemic K562 cells. Leuk. Lymphoma 51 (2010), 694–701.
121. Huang, V., Li, L.C., miRNA goes nuclear. RNA Biol. 9 (2012), 269–273.
122. Huang, V., Qin, Y., Wang, J., Wang, X., Place, R.F., Lin, G., Lue, T.F., Li, L.C., RNAa is conserved in mammalian cells. PLoS One, 5, 2010, e8848.
123. Huang, V., Place, R.F., Portnoy, V., Wang, J., Qi, Z., Jia, Z., Yu, A., Shuman, M., Yu, J., Li, L.C., Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 40 (2012), 1695–1707.
124. Humphreys, D.T., Westman, B.J., Martin, D.I., Preiss, T., MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U.S.A. 102 (2005), 16961–16966.
125. Huse, J.T., Brennan, C., Hambardzumyan, D., Wee, B., Pena, J., Rouhanifard, S.H., Sohn-Lee, C., Le Sage, C., Agami, R., Tuschl, T., Holland, E.C., The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 23 (2009), 1327–1337.
126. Hutvagner, G., Mclachlan, J., Pasquinelli, A.E., Balint, E., Tuschl, T., Zamore, P.D., A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293 (2001), 834–838.
127. Hutvagner, G., Simard, M.J., Mello, C.C., Zamore, P.D., Sequence-specific inhibition of small RNA function. PLoS Biol., 2, 2004, E98.
128. Hwang, H.W., Wentzel, E.A., Mendell, J.T., A hexanucleotide element directs microRNA nuclear import. Science 315 (2007), 97–100.
129. Ipsaro, J.J., Joshua-Tor, L., From guide to target: molecular insights into eukaryotic RNA-interference machinery. Nat. Struct. Mol. Biol. 22 (2015), 20–28.
130. Izant, J.G., Weintraub, H., Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 36 (1984), 1007–1015.
131. Jeck, W.R., Sharpless, N.E., Detecting and characterizing circular RNAs. Nat. Biotechnol. 32 (2014), 453–461.
132. Jens, M., Rajewsky, N., Competition between target sites of regulators shapes post-transcriptional gene regulation. Nat. Rev. Genet. 16 (2015), 113–126.
133. Jeyapalan, Z., Deng, Z., Shatseva, T., Fang, L., He, C., Yang, B.B., Expression of CD44 3’-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 39 (2011), 3026–3041.
134. Jiang, X., Hu, C., Arnovitz, S., Bugno, J., Yu, M., Zuo, Z., Chen, P., Huang, H., Ulrich, B., Gurbuxani, S., Weng, H., Strong, J., Wang, Y., Li, Y., Salat, J., Li, S., Elkahloun, A.G., Yang, Y., Neilly, M.B., Larson, R.A., Le Beau, M.M., Herold, T., Bohlander, S.K., Liu, P.P., Zhang, J., Li, Z., He, C., Jin, J., Hong, S., Chen, J., miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia. Nat. Commun., 7, 2016, 11452.
135. Jiao, A.L., Slack, F.J., RNA-mediated gene activation. Epigenetics 9 (2014), 27–36.
136. Jin, P., Wang, E., Ren, J., Childs, R., Shin, J.W., Khuu, H., Marincola, F.M., Stroncek, D.F., Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis. J. Transl. Med., 6, 2008, 39.
137. Johnnidis, J.B., Harris, M.H., Wheeler, R.T., Stehling-Sun, S., Lam, M.H., Kirak, O., Brummelkamp, T.R., Fleming, M.D., Camargo, F.D., Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451 (2008), 1125–1129.
138. Johnson, S.M., Lin, S.Y., Slack, F.J., The time of appearance of the C. elegans let-7 microRNA is transcriptionally controlled utilizing a temporal regulatory element in its promoter. Dev. Biol. 259 (2003), 364–379.
139. Johnson, S.M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K.L., Brown, D., Slack, F.J., RAS is regulated by the let-7 microRNA family. Cell 120 (2005), 635–647.
140. Johnsson, P., Ackley, A., Vidarsdottir, L., Lui, W.O., Corcoran, M., Grander, D., Morris, K.V., A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat. Struct. Mol. Biol. 20 (2013), 440–446.
141. Johnston, R.J., Hobert, O., A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 426 (2003), 845–849.
142. Jonas, S., Izaurralde, E., Towards a molecular understanding of microRNA-mediated gene silencing. Nat. Rev. Genet. 16 (2015), 421–433.
143. Jongen-Lavrencic, M., Sun, S.M., Dijkstra, M.K., Valk, P.J., Lowenberg, B., MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111 (2008), 5078–5085.
144. Jopling, C.L., Yi, M., Lancaster, A.M., Lemon, S.M., Sarnow, P., Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 (2005), 1577–1581.
145. Karreth, F.A., Tay, Y., Perna, D., Ala, U., Tan, S.M., Rust, A.G., Denicola, G., Webster, K.A., Weiss, D., Perez-Mancera, P.A., Krauthammer, M., Halaban, R., Provero, P., Adams, D.J., Tuveson, D.A., Pandolfi, P.P., In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147 (2011), 382–395.
146. Karreth, F.A., Reschke, M., Ruocco, A., Ng, C., Chapuy, B., Leopold, V., Sjoberg, M., Keane, T.M., Verma, A., Ala, U., Tay, Y., Wu, D., Seitzer, N., Velasco-Herrera Mdel, C., Bothmer, A., Fung, J., Langellotto, F., Rodig, S.J., Elemento, O., Shipp, M.A., Adams, D.J., Chiarle, R., Pandolfi, P.P., The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell 161 (2015), 319–332.
147. Karube, Y., Tanaka, H., Osada, H., Tomida, S., Tatematsu, Y., Yanagisawa, K., Yatabe, Y., Takamizawa, J., Miyoshi, S., Mitsudomi, T., Takahashi, T., Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci. 96 (2005), 111–115.
148. Kato, M., Putta, S., Wang, M., Yuan, H., Lanting, L., Nair, I., Gunn, A., Nakagawa, Y., Shimano, H., Todorov, I., Rossi, J.J., Natarajan, R., TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11 (2009), 881–889.
149. Kawahara, Y., Zinshteyn, B., Chendrimada, T.P., Shiekhattar, R., Nishikura, K., RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 8 (2007), 763–769.
150. Kawahara, H., Okada, Y., Imai, T., Iwanami, A., Mischel, P.S., Okano, H., Musashi1 cooperates in abnormal cell lineage protein 28 (Lin28)-mediated let-7 family microRNA biogenesis in early neural differentiation. J. Biol. Chem. 286 (2011), 16121–16130.
151. Ketting, R.F., Fischer, S.E., Bernstein, E., Sijen, T., Hannon, G.J., Plasterk, R.H., Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15 (2001), 2654–2659.
152. Kharas, M.G., Lengner, C.J., Al-Shahrour, F., Bullinger, L., Ball, B., Zaidi, S., Morgan, K., Tam, W., Paktinat, M., Okabe, R., Gozo, M., Einhorn, W., Lane, S.W., Scholl, C., Frohling, S., Fleming, M., Ebert, B.L., Gilliland, D.G., Jaenisch, R., Daley, G.Q., Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia. Nat. Med. 16 (2010), 903–908.
153. Khvorova, A., Reynolds, A., Jayasena, S.D., Functional siRNAs and miRNAs exhibit strand bias. Cell 115 (2003), 209–216.
154. Kim, J., Krichevsky, A., Grad, Y., Hayes, G.D., Kosik, K.S., Church, G.M., Ruvkun, G., Identification of many microRNAs that copurify with polyribosomes in mammalian neurons. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 360–365.
155. Kloosterman, W.P., Lagendijk, A.K., Ketting, R.F., Moulton, J.D., Plasterk, R.H., Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol., 5, 2007, e203.
156. Kluiver, J., Poppema, S., De Jong, D., Blokzijl, T., Harms, G., Jacobs, S., Kroesen, B.J., Van Den Berg, A., BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207 (2005), 243–249.
157. Klusmann, J.H., Li, Z., Bohmer, K., Maroz, A., Koch, M.L., Emmrich, S., Godinho, F.J., Orkin, S.H., Reinhardt, D., miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. Genes Dev. 24 (2010), 478–490.
158. Kortylewski, M., Swiderski, P., Herrmann, A., Wang, L., Kowolik, C., Kujawski, M., Lee, H., Scuto, A., Liu, Y., Yang, C., Deng, J., Soifer, H.S., Raubitschek, A., Forman, S., Rossi, J.J., Pardoll, D.M., Jove, R., Yu, H., In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 27 (2009), 925–932.
159. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., Macmenamin, P., Da Piedade, I., Gunsalus, K.C., Stoffel, M., Rajewsky, N., Combinatorial microRNA target predictions. Nat. Genet. 37 (2005), 495–500.
160. Kristiansen, T.A., Jaensson Gyllenback, E., Zriwil, A., Bjorklund, T., Daniel, J.A., Sitnicka, E., Soneji, S., Bryder, D., Yuan, J., Cellular barcoding links B-1a B cell potential to a fetal hematopoietic stem cell state at the single-cell level. Immunity 45 (2016), 346–357.
161. Krol, J., Sobczak, K., Wilczynska, U., Drath, M., Jasinska, A., Kaczynska, D., Krzyzosiak, W.J., Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA/short hairpin RNA design. J. Biol. Chem. 279 (2004), 42230–42239.
162. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M., Stoffel, M., Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438 (2005), 685–689.
163. Kuchenbauer, F., Mah, S.M., Heuser, M., Mcpherson, A., Ruschmann, J., Rouhi, A., Berg, T., Bullinger, L., Argiropoulos, B., Morin, R.D., Lai, D., Starczynowski, D.T., Karsan, A., Eaves, C.J., Watahiki, A., Wang, Y., Aparicio, S.A., Ganser, A., Krauter, J., Dohner, H., Dohner, K., Marra, M.A., Camargo, F.D., Palmqvist, L., Buske, C., Humphries, R.K., Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells. Blood 118 (2011), 3350–3358.
164. Kudla, G., Granneman, S., Hahn, D., Beggs, J.D., Tollervey, D., Cross-linking, ligation, and sequencing of hybrids reveals RNA-RNA interactions in yeast. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 10010–10015.
165. Kumar, P., Lee, S.K., Shankar, P., Manjunath, N., A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med., 3, 2006, e96.
166. Labbaye, C., Spinello, I., Quaranta, M.T., Pelosi, E., Pasquini, L., Petrucci, E., Biffoni, M., Nuzzolo, E.R., Billi, M., Foa, R., Brunetti, E., Grignani, F., Testa, U., Peschle, C., A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat. Cell Biol. 10 (2008), 788–801.
167. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., Tuschl, T., Identification of novel genes coding for small expressed RNAs. Science 294 (2001), 853–858.
168. Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., Tuschl, T., Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12 (2002), 735–739.
169. Lagos-Quintana, M., Rauhut, R., Meyer, J., Borkhardt, A., Tuschl, T., New microRNAs from mouse and human. RNA 9 (2003), 175–179.
170. Lal, A., Navarro, F., Maher, C.A., Maliszewski, L.E., Yan, N., O'DAY, E., Chowdhury, D., Dykxhoorn, D.M., Tsai, P., Hofmann, O., Becker, K.G., Gorospe, M., Hide, W., Lieberman, J., miR-24 inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to “seedless” 3’UTR microRNA recognition elements. Mol. Cell 35 (2009), 610–625.
171. Lanford, R.E., Hildebrandt-Eriksen, E.S., Petri, A., Persson, R., Lindow, M., Munk, M.E., Kauppinen, S., Orum, H., Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327 (2010), 198–201.
172. Lau, N.C., Lim, L.P., Weinstein, E.G., Bartel, D.P., An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294 (2001), 858–862.
173. Lawrie, C.H., MicroRNAs in hematological malignancies. Blood Rev. 27 (2013), 143–154.
174. Lawrie, C.H., Soneji, S., Marafioti, T., Cooper, C.D., Palazzo, S., Paterson, J.C., Cattan, H., Enver, T., Mager, R., Boultwood, J., Wainscoat, J.S., Hatton, C.S., MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121 (2007), 1156–1161.
175. Lawrie, C.H., Gal, S., Dunlop, H.M., Pushkaran, B., Liggins, A.P., Pulford, K., Banham, A.H., Pezzella, F., Boultwood, J., Wainscoat, J.S., Hatton, C.S., Harris, A.L., Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141 (2008), 672–675.
176. Le, M.T., Xie, H., Zhou, B., Chia, P.H., Rizk, P., Um, M., Udolph, G., Yang, H., Lim, B., Lodish, H.F., MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets. Mol. Cell. Biol. 29 (2009), 5290–5305.
177. Lechman, E.R., Gentner, B., Ng, S.W., Schoof, E.M., Van Galen, P., Kennedy, J.A., Nucera, S., Ciceri, F., Kaufmann, K.B., Takayama, N., Dobson, S.M., Trotman-Grant, A., Krivdova, G., Elzinga, J., Mitchell, A., Nilsson, B., Hermans, K.G., Eppert, K., Marke, R., Isserlin, R., Voisin, V., Bader, G.D., Zandstra, P.W., Golub, T.R., Ebert, B.L., Lu, J., Minden, M., Wang, J.C., Naldini, L., Dick, J.E., miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell 29 (2016), 214–228.
178. Lee, R.C., Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001), 862–864.
179. Lee, R.C., Feinbaum, R.L., Ambros, V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993), 843–854.
180. Lee, Y., Jeon, K., Lee, J.T., Kim, S., Kim, V.N., MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21 (2002), 4663–4670.
181. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Radmark, O., Kim, S., Kim, V.N., The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003), 415–419.
182. Lee, Y., Kim, M., Han, J., Yeom, K.H., Lee, S., Baek, S.H., Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23 (2004), 4051–4060.
183. Lee, D.Y., Jeyapalan, Z., Fang, L., Yang, J., Zhang, Y., Yee, A.Y., Li, M., Du, W.W., Shatseva, T., Yang, B.B., Expression of versican 3’-untranslated region modulates endogenous microRNA functions. PLoS One, 5, 2010, e13599.
184. Lee, H., Lytton-Jean, A.K., Chen, Y., Love, K.T., Park, A.I., Karagiannis, E.D., Sehgal, A., Querbes, W., Zurenko, C.S., Jayaraman, M., Peng, C.G., Charisse, K., Borodovsky, A., Manoharan, M., Donahoe, J.S., Truelove, J., Nahrendorf, M., Langer, R., Anderson, D.G., Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7 (2012), 389–393.
185. Lennox, K.A., Behlke, M.A., Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 18 (2011), 1111–1120.
186. Lennox, K.A., Owczarzy, R., Thomas, D.M., Walder, J.A., Behlke, M.A., Improved performance of anti-miRNA oligonucleotides using a novel non-nucleotide modifier. Mol. Ther. Nucleic Acids, 2, 2013, e117.
187. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
188. Li, Z., Rana, T.M., Therapeutic targeting of microRNAs: current status and future challenges. Nat. Rev. Drug Discov. 13 (2014), 622–638.
189. Li, Z., Lu, J., Sun, M., Mi, S., Zhang, H., Luo, R.T., Chen, P., Wang, Y., Yan, M., Qian, Z., Neilly, M.B., Jin, J., Zhang, Y., Bohlander, S.K., Zhang, D.E., Larson, R.A., Le Beau, M.M., Thirman, M.J., Golub, T.R., Rowley, J.D., Chen, J., Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 15535–15540.
190. Li, Y., Zhu, X., Gu, J., Dong, D., Yao, J., Lin, C., Huang, K., Fei, J., Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci. 101 (2010), 948–954.
191. Li, Z., Yang, C.S., Nakashima, K., Rana, T.M., Small RNA-mediated regulation of iPS cell generation. EMBO J. 30 (2011), 823–834.
192. Li, X., Zhang, J., Gao, L., Mcclellan, S., Finan, M.A., Butler, T.W., Owen, L.B., Piazza, G.A., Xi, Y., MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ. 19 (2012), 378–386.
193. Liao, R., Sun, J., Zhang, L., Lou, G., Chen, M., Zhou, D., Chen, Z., Zhang, S., MicroRNAs play a role in the development of human hematopoietic stem cells. J. Cell. Biochem. 104 (2008), 805–817.
194. Lim, L.P., Glasner, M.E., Yekta, S., Burge, C.B., Bartel, D.P., Vertebrate microRNA genes. Science, 299, 2003, 1540.
195. Lim, L.P., Lau, N.C., Weinstein, E.G., Abdelhakim, A., Yekta, S., Rhoades, M.W., Burge, C.B., Bartel, D.P., The microRNAs of Caenorhabditis elegans. Genes Dev. 17 (2003), 991–1008.
196. Lin, C.C., Liu, L.Z., Addison, J.B., Wonderlin, W.F., Ivanov, A.V., Ruppert, J.M., A KLF4-miRNA-206 autoregulatory feedback loop can promote or inhibit protein translation depending upon cell context. Mol. Cell. Biol. 31 (2011), 2513–2527.
197. Lindow, M., Kauppinen, S., Discovering the first microRNA-targeted drug. J. Cell Biol. 199 (2012), 407–412.
198. Ling, B., Wang, G.X., Long, G., Qiu, J.H., Hu, Z.L., Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3. J. Cancer Res. Clin. Oncol. 138 (2012), 1355–1361.
199. Ling, H., Fabbri, M., Calin, G.A., MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat. Rev. Drug Discov. 12 (2013), 847–865.
200. Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M., Joshua-Tor, L., Hannon, G.J., Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004), 1437–1441.
201. Liu, S., Shen, T., Huynh, L., Klisovic, M.I., Rush, L.J., Ford, J.L., Yu, J., Becknell, B., Li, Y., Liu, C., Vukosavljevic, T., Whitman, S.P., Chang, K.S., Byrd, J.C., Perrotti, D., Plass, C., Marcucci, G., Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res. 65 (2005), 1277–1284.
202. Liu, Y., Cheney, M.D., Gaudet, J.J., Chruszcz, M., Lukasik, S.M., Sugiyama, D., Lary, J., Cole, J., Dauter, Z., Minor, W., Speck, N.A., Bushweller, J.H., The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell 9 (2006), 249–260.
203. Liu, Y., Ye, X., Jiang, F., Liang, C., Chen, D., Peng, J., Kinch, L.N., Grishin, N.V., Liu, Q., C3PO, an endoribonuclease that promotes RNAi by facilitating RISC activation. Science 325 (2009), 750–753.
204. Liu, S., Wu, L.C., Pang, J., Santhanam, R., Schwind, S., Wu, Y.Z., Hickey, C.J., Yu, J., Becker, H., Maharry, K., Radmacher, M.D., Li, C., Whitman, S.P., Mishra, A., Stauffer, N., Eiring, A.M., Briesewitz, R., Baiocchi, R.A., Chan, K.K., Paschka, P., Caligiuri, M.A., Byrd, J.C., Croce, C.M., Bloomfield, C.D., Perrotti, D., Garzon, R., Marcucci, G., Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17 (2010), 333–347.
205. Lujambio, A., Calin, G.A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., Montuenga, L.M., Rossi, S., Nicoloso, M.S., Faller, W.J., Gallagher, W.M., Eccles, S.A., Croce, C.M., Esteller, M., A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 13556–13561.
206. Lund, E., Dahlberg, J.E., Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb. Symp. Quant. Biol. 71 (2006), 59–66.
207. Lund, E., Guttinger, S., Calado, A., Dahlberg, J.E., Kutay, U., Nuclear export of microRNA precursors. Science 303 (2004), 95–98.
208. Majid, S., Dar, A.A., Saini, S., Yamamura, S., Hirata, H., Tanaka, Y., Deng, G., Dahiya, R., MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 116 (2010), 5637–5649.
209. Majlessi, M., Nelson, N.C., Becker, M.M., Advantages of 2’-O-methyl oligoribonucleotide probes for detecting RNA targets. Nucleic Acids Res. 26 (1998), 2224–2229.
210. Marques, A.C., Tan, J., Lee, S., Kong, L., Heger, A., Ponting, C.P., Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAs. Genome Biol., 13, 2012, R102.
211. Mathonnet, G., Fabian, M.R., Svitkin, Y.V., Parsyan, A., Huck, L., Murata, T., Biffo, S., Merrick, W.C., Darzynkiewicz, E., Pillai, R.S., Filipowicz, W., Duchaine, T.F., Sonenberg, N., MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317 (2007), 1764–1767.
212. Mavrakis, K.J., Wolfe, A.L., Oricchio, E., Palomero, T., De Keersmaecker, K., Mcjunkin, K., Zuber, J., James, T., Khan, A.A., Leslie, C.S., Parker, J.S., Paddison, P.J., Tam, W., Ferrando, A., Wendel, H.G., Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat. Cell Biol. 12 (2010), 372–379.
213. Mayr, C., Hemann, M.T., Bartel, D.P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007), 1576–1579.
214. Mcpherson, J.D., Marra, M., Hillier, L., Waterston, R.H., Chinwalla, A., Wallis, J., Sekhon, M., Wylie, K., Mardis, E.R., Wilson, R.K., Fulton, R., Kucaba, T.A., Wagner-Mcpherson, C., Barbazuk, W.B., Gregory, S.G., Humphray, S.J., French, L., Evans, R.S., Bethel, G., Whittaker, A., Holden, J.L., Mccann, O.T., Dunham, A., Soderlund, C., Scott, C.E., Bentley, D.R., Schuler, G., Chen, H.C., Jang, W., Green, E.D., Idol, J.R., Maduro, V.V., Montgomery, K.T., Lee, E., Miller, A., Emerling, S., Kucherlapati, Gibbs, R., Scherer, S., Gorrell, J.H., Sodergren, E., Clerc-Blankenburg, K., Tabor, P., Naylor, S., Garcia, D., De Jong, P.J., Catanese, J.J., Nowak, N., Osoegawa, K., Qin, S., Rowen, L., Madan, A., Dors, M., Hood, L., Trask, B., Friedman, C., Massa, H., Cheung, V.G., Kirsch, I.R., Reid, T., Yonescu, R., Weissenbach, J., Bruls, T., Heilig, R., Branscomb, E., Olsen, A., Doggett, N., Cheng, J.F., Hawkins, T., Myers, R.M., Shang, J., Ramirez, L., Schmutz, J., Velasquez, O., Dixon, K., Stone, N.E., Cox, D.R., Haussler, D., Kent, W.J., Furey, T., Rogic, S., Kennedy, S., Jones, S., Rosenthal, A., Wen, G., Schilhabel, M., Gloeckner, G., Nyakatura, G., Siebert, R., Schlegelberger, B., Korenberg, J., Chen, X.N., Fujiyama, A., Hattori, M., Toyoda, A., Yada, T., Park, H.S., Sakaki, Y., Shimizu, N., Asakawa, S., et al. A physical map of the human genome. Nature 409 (2001), 934–941.
215. Medina, P.P., Nolde, M., Slack, F.J., OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467 (2010), 86–90.
216. Meister, G., Landthaler, M., Dorsett, Y., Tuschl, T., Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10 (2004), 544–550.
217. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., Tuschl, T., Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15 (2004), 185–197.
218. Melo, S.A., Ropero, S., Moutinho, C., Aaltonen, L.A., Yamamoto, H., Calin, G.A., Rossi, S., Fernandez, A.F., Carneiro, F., Oliveira, C., Ferreira, B., Liu, C.G., Villanueva, A., Capella, G., Schwartz, S. Jr., Shiekhattar, R., Esteller, M., A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat. Genet. 41 (2009), 365–370.
219. Melo, S.A., Moutinho, C., Ropero, S., Calin, G.A., Rossi, S., Spizzo, R., Fernandez, A.F., Davalos, V., Villanueva, A., Montoya, G., Yamamoto, H., Schwartz, S. Jr., Esteller, M., A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18 (2010), 303–315.
220. Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S.D., Gregersen, L.H., Munschauer, M., Loewer, A., Ziebold, U., Landthaler, M., Kocks, C., Le Noble, F., Rajewsky, N., Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495 (2013), 333–338.
221. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T., Patel, T., MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007), 647–658.
222. Merkerova, M., Vasikova, A., Belickova, M., Bruchova, H., MicroRNA expression profiles in umbilical cord blood cell lineages. Stem Cells Dev. 19 (2010), 17–26.
223. Merritt, W.M., Lin, Y.G., Han, L.Y., Kamat, A.A., Spannuth, W.A., Schmandt, R., Urbauer, D., Pennacchio, L.A., Cheng, J.F., Nick, A.M., Deavers, M.T., Mourad-Zeidan, A., Wang, H., Mueller, P., Lenburg, M.E., Gray, J.W., Mok, S., Birrer, M.J., Lopez-Berestein, G., Coleman, R.L., Bar-Eli, M., Sood, A.K., Dicer, Drosha, and outcomes in patients with ovarian cancer. N. Engl. J. Med. 359 (2008), 2641–2650.
224. Mi, S., Lu, J., Sun, M., Li, Z., Zhang, H., Neilly, M.B., Wang, Y., Qian, Z., Jin, J., Zhang, Y., Bohlander, S.K., Le Beau, M.M., Larson, R.A., Golub, T.R., Rowley, J.D., Chen, J., MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 19971–19976.
225. Michael, M.Z., Sm, O.C., Van Holst Pellekaan, N.G., Young, G.P., James, R.J., Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1 (2003), 882–891.
226. Mitchell, P.S., Parkin, R.K., Kroh, E.M., Fritz, B.R., Wyman, S.K., Pogosova-Agadjanyan, E.L., Peterson, A., Noteboom, J., O'BRIANT, K.C., Allen, A., Lin, D.W., Urban, N., Drescher, C.W., Knudsen, B.S., Stirewalt, D.L., Gentleman, R., Vessella, R.L., Nelson, P.S., Martin, D.B., Tewari, M., Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 10513–10518.
227. Morrissey, D.V., Lockridge, J.A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., Vaish, N., Zinnen, S., Vargeese, C., Bowman, K., Shaffer, C.S., Jeffs, L.B., Judge, A., Maclachlan, I., Polisky, B., Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat. Biotechnol. 23 (2005), 1002–1007.
228. Mott, J.L., Kobayashi, S., Bronk, S.F., Gores, G.J., mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26 (2007), 6133–6140.
229. Mouse Genome Sequencing Consortium, Waterston, R.H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J.F., Agarwal, P., Agarwala, R., Ainscough, R., Alexandersson, M., An, P., Antonarakis, S.E., Attwood, J., Baertsch, R., Bailey, J., Barlow, K., Beck, S., Berry, E., Birren, B., Bloom, T., Bork, P., Botcherby, M., Bray, N., Brent, M.R., Brown, D.G., Brown, S.D., Bult, C., Burton, J., Butler, J., Campbell, R.D., Carninci, P., Cawley, S., Chiaromonte, F., Chinwalla, A.T., Church, D.M., Clamp, M., Clee, C., Collins, F.S., Cook, L.L., Copley, R.R., Coulson, A., Couronne, O., Cuff, J., Curwen, V., Cutts, T., Daly, M., David, R., Davies, J., Delehaunty, K.D., Deri, J., Dermitzakis, E.T., Dewey, C., Dickens, N.J., Diekhans, M., Dodge, S., Dubchak, I., Dunn, D.M., Eddy, S.R., Elnitski, L., Emes, R.D., Eswara, P., Eyras, E., Felsenfeld, A., Fewell, G.A., Flicek, P., Foley, K., Frankel, W.N., Fulton, L.A., Fulton, R.S., Furey, T.S., Gage, D., Gibbs, R.A., Glusman, G., Gnerre, S., Goldman, N., Goodstadt, L., Grafham, D., Graves, T.A., Green, E.D., Gregory, S., Guigo, R., Guyer, M., Hardison, R.C., Haussler, D., Hayashizaki, Y., Hillier, L.W., Hinrichs, A., Hlavina, W., Holzer, T., Hsu, F., Hua, A., Hubbard, T., Hunt, A., Jackson, I., Jaffe, D.B., Johnson, L.S., Jones, M., Jones, T.A., Joy, A., Kamal, M., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420 (2002), 520–562.
230. Mullokandov, G., Baccarini, A., Ruzo, A., Jayaprakash, A.D., Tung, N., Israelow, B., Evans, M.J., Sachidanandam, R., Brown, B.D., High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 9 (2012), 840–846.
231. Muralidhar, B., Goldstein, L.D., Ng, G., Winder, D.M., Palmer, R.D., Gooding, E.L., Barbosa-Morais, N.L., Mukherjee, G., Thorne, N.P., Roberts, I., Pett, M.R., Coleman, N., Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J. Pathol. 212 (2007), 368–377.
232. Nellen, W., Lichtenstein, C., What makes an mRNA anti-sense-itive?. Trends Biochem. Sci. 18 (1993), 419–423.
233. Newman, M.A., Thomson, J.M., Hammond, S.M., Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14 (2008), 1539–1549.
234. Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., Yokota, T., Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol. Mol. Ther. 16 (2008), 734–740.
235. Nowek, K., Sun, S.M., Dijkstra, M.K., Bullinger, L., Dohner, H., Erkeland, S.J., Lowenberg, B., Jongen-Lavrencic, M., Expression of a passenger miR-9* predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age. Leukemia 30 (2016), 303–309.
236. Obad, S., Dos Santos, C.O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E.M., Hansen, H.F., Koch, T., Pappin, D., Hannon, G.J., Kauppinen, S., Silencing of microRNA families by seed-targeting tiny LNAs. Nat. Genet. 43 (2011), 371–378.
237. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., Mendell, J.T., c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005), 839–843.
238. Okamura, K., Hagen, J.W., Duan, H., Tyler, D.M., Lai, E.C., The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130 (2007), 89–100.
239. Ooi, A.G., Sahoo, D., Adorno, M., Wang, Y., Weissman, I.L., Park, C.Y., MicroRNA-125b expands hematopoietic stem cells and enriches for the lymphoid-balanced and lymphoid-biased subsets. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 21505–21510.
240. Ota, A., Tagawa, H., Karnan, S., Tsuzuki, S., Karpas, A., Kira, S., Yoshida, Y., Seto, M., Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64 (2004), 3087–3095.
241. Palliser, D., Chowdhury, D., Wang, Q.Y., Lee, S.J., Bronson, R.T., Knipe, D.M., Lieberman, J., An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439 (2006), 89–94.
242. Pampalakis, G., Diamandis, E.P., Katsaros, D., Sotiropoulou, G., Down-regulation of dicer expression in ovarian cancer tissues. Clin. Biochem. 43 (2010), 324–327.
243. Park, J.K., Kogure, T., Nuovo, G.J., Jiang, J., He, L., Kim, J.H., Phelps, M.A., Papenfuss, T.L., Croce, C.M., Patel, T., Schmittgen, T.D., miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res. 71 (2011), 7608–7616.
244. Pasquinelli, A.E., Reinhart, B.J., Slack, F., Martindale, M.Q., Kuroda, M.I., Maller, B., Hayward, D.C., Ball, E.E., Degnan, B., Muller, P., Spring, J., Srinivasan, A., Fishman, M., Finnerty, J., Corbo, J., Levine, M., Leahy, P., Davidson, E., Ruvkun, G., Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (2000), 86–89.
245. Pedersen, I.M., Otero, D., Kao, E., Miletic, A.V., Hother, C., Ralfkiaer, E., Rickert, R.C., Gronbaek, K., David, M., Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. EMBO Mol. Med. 1 (2009), 288–295.
246. Pekarsky, Y., Hallas, C., Croce, C.M., The role of TCL1 in human T-cell leukemia. Oncogene 20 (2001), 5638–5643.
247. Pekarsky, Y., Santanam, U., Cimmino, A., Palamarchuk, A., Efanov, A., Maximov, V., Volinia, S., Alder, H., Liu, C.G., Rassenti, L., Calin, G.A., Hagan, J.P., Kipps, T., Croce, C.M., Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 66 (2006), 11590–11593.
248. Pelosi, A., Careccia, S., Lulli, V., Romania, P., Marziali, G., Testa, U., Lavorgna, S., Lo-Coco, F., Petti, M.C., Calabretta, B., Levrero, M., Piaggio, G., Rizzo, M.G., miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. Oncogene 32 (2013), 3648–3654.
249. Pillai, R.S., Bhattacharyya, S.N., Artus, C.G., Zoller, T., Cougot, N., Basyuk, E., Bertrand, E., Filipowicz, W., Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309 (2005), 1573–1576.
250. Place, R.F., Li, L.C., Pookot, D., Noonan, E.J., Dahiya, R., MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 1608–1613.
251. Poliseno, L., Salmena, L., Zhang, J., Carver, B., Haveman, W.J., Pandolfi, P.P., A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465 (2010), 1033–1038.
252. Raaijmakers, M.H., Mukherjee, S., Guo, S., Zhang, S., Kobayashi, T., Schoonmaker, J.A., Ebert, B.L., Al-Shahrour, F., Hasserjian, R.P., Scadden, E.O., Aung, Z., Matza, M., Merkenschlager, M., Lin, C., Rommens, J.M., Scadden, D.T., Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia. Nature 464 (2010), 852–857.
253. Raghavachari, N., Liu, P., Barb, J.J., Yang, Y., Wang, R., Nguyen, Q.T., Munson, P.J., Integrated analysis of miRNA and mRNA during differentiation of human CD34 + cells delineates the regulatory roles of microRNA in hematopoiesis. Exp. Hematol. 42:14–27 (2014), e1–e2.
254. Rai, D., Kim, S.W., Mckeller, M.R., Dahia, P.L., Aguiar, R.C., Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis. Proc. Natl. Acad. Sci. U.S.A. 107 (2010), 3111–3116.
255. Rao, P.H., Houldsworth, J., Dyomina, K., Parsa, N.Z., Cigudosa, J.C., Louie, D.C., Popplewell, L., Offit, K., Jhanwar, S.C., Chaganti, R.S., Chromosomal and gene amplification in diffuse large B-cell lymphoma. Blood 92 (1998), 234–240.
256. Rehwinkel, J., Behm-Ansmant, I., Gatfield, D., Izaurralde, E., A crucial role for GW182 and the DCP1:DCP2 decapping complex in miRNA-mediated gene silencing. RNA 11 (2005), 1640–1647.
257. Reinhart, B.J., Slack, F.J., Basson, M., Pasquinelli, A.E., Bettinger, J.C., Rougvie, A.E., Horvitz, H.R., Ruvkun, G., The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000), 901–906.
258. Ricci, E.P., Limousin, T., Soto-Rifo, R., Rubilar, P.S., Decimo, D., Ohlmann, T., miRNA repression of translation in vitro takes place during 43S ribosomal scanning. Nucleic Acids Res. 41 (2013), 586–598.
259. Robb, G.B., Brown, K.M., Khurana, J., Rana, T.M., Specific and potent RNAi in the nucleus of human cells. Nat. Struct. Mol. Biol. 12 (2005), 133–137.
260. Roberts, T.C., The microRNA biology of the mammalian nucleus. Mol. Ther. Nucleic Acids, 3, 2014, e188.
261. Rodriguez, A., Griffiths-Jones, S., Ashurst, J.L., Bradley, A., Identification of mammalian microRNA host genes and transcription units. Genome Res. 14 (2004), 1902–1910.
262. Rossi, S., Shimizu, M., Barbarotto, E., Nicoloso, M.S., Dimitri, F., Sampath, D., Fabbri, M., Lerner, S., Barron, L.L., Rassenti, L.Z., Jiang, L., Xiao, L., Hu, J., Secchiero, P., Zauli, G., Volinia, S., Negrini, M., Wierda, W., Kipps, T.J., Plunkett, W., Coombes, K.R., Abruzzo, L.V., Keating, M.J., Calin, G.A., microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood 116 (2010), 945–952.
263. Ruby, J.G., Jan, C.H., Bartel, D.P., Intronic microRNA precursors that bypass Drosha processing. Nature 448 (2007), 83–86.
264. Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E.E., Nitsch, R., Wulczyn, F.G., A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol. 10 (2008), 987–993.
265. Salah, Z., Arafeh, R., Maximov, V., Galasso, M., Khawaled, S., Abou-Sharieha, S., Volinia, S., Jones, K.B., Croce, C.M., Aqeilan, R.I., miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Oncotarget 6 (2015), 4920–4935.
266. Salmena, L., Poliseno, L., Tay, Y., Kats, L., Pandolfi, P.P., A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?. Cell 146 (2011), 353–358.
267. Sand, M., Gambichler, T., Skrygan, M., Sand, D., Scola, N., Altmeyer, P., Bechara, F.G., Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. Cancer Invest. 28 (2010), 649–653.
268. Schirle, N.T., Sheu-Gruttadauria, J., Macrae, I.J., Structural basis for microRNA targeting. Science 346 (2014), 608–613.
269. Schultz, K.A., Pacheco, M.C., Yang, J., Williams, G.M., Messinger, Y., Hill, D.A., Dehner, L.P., Priest, J.R., Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry. Gynecol. Oncol. 122 (2011), 246–250.
270. Schwarz, D.S., Zamore, P.D., Why do miRNAs live in the miRNP?. Genes Dev. 16 (2002), 1025–1031.
271. Schwarz, D.S., Hutvagner, G., Du, T., Xu, Z., Aronin, N., Zamore, P.D., Asymmetry in the assembly of the RNAi enzyme complex. Cell 115 (2003), 199–208.
272. Shen, C., Chen, M.T., Zhang, X.H., Yin, X.L., Ning, H.M., Su, R., Lin, H.S., Song, L., Wang, F., Ma, Y.N., Zhao, H.L., Yu, J., Zhang, J.W., The PU.1-modulated microRNA-22 is a regulator of monocyte/macrophage differentiation and acute myeloid leukemia. PLoS Genet., 12, 2016, e1006259.
273. Shi, X.B., Xue, L., Yang, J., Ma, A.H., Zhao, J., Xu, M., Tepper, C.G., Evans, C.P., Kung, H.J., Devere White, R.W., An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 104 (2007), 19983–19988.
274. Shin, C., Nam, J.W., Farh, K.K., Chiang, H.R., Shkumatava, A., Bartel, D.P., Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell 38 (2010), 789–802.
275. Singh, S.K., Kumar, R., Wengel, J., Synthesis of novel bicyclo[2.2.1] ribonucleosides: 2’-amino- and 2’-thio-LNA monomeric nucleosides. J. Org. Chem. 63 (1998), 6078–6079.
276. Sokol, L., Caceres, G., Volinia, S., Alder, H., Nuovo, G.J., Liu, C.G., Mcgraw, K., Clark, J.A., Sigua, C.A., Chen, D.T., Moscinski, L., Croce, C.M., List, A.F., Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br. J. Haematol. 153 (2011), 24–32.
277. Song, J.J., Smith, S.K., Hannon, G.J., Joshua-Tor, L., Crystal structure of argonaute and its implications for RISC slicer activity. Science 305 (2004), 1434–1437.
278. Song, E., Zhu, P., Lee, S.K., Chowdhury, D., Kussman, S., Dykxhoorn, D.M., Feng, Y., Palliser, D., Weiner, D.B., Shankar, P., Marasco, W.A., Lieberman, J., Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23 (2005), 709–717.
279. Song, S.J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S.M., Jongen-Lavrencic, M., Manova-Todorova, K., Teruya-Feldstein, J., Avigan, D.E., Delwel, R., Pandolfi, P.P., The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 13 (2013), 87–101.
280. Song, S.J., Poliseno, L., Song, M.S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N.J., Yuan, X., Cantley, L.C., Richardson, A.L., Pandolfi, P.P., MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154 (2013), 311–324.
281. Spizzo, R., Nicoloso, M.S., Croce, C.M., Calin, G.A., SnapShot: microRNAs in cancer. Cell, 137, 2009, 586 e1.
282. Starczynowski, D.T., Morin, R., Mcpherson, A., Lam, J., Chari, R., Wegrzyn, J., Kuchenbauer, F., Hirst, M., Tohyama, K., Humphries, R.K., Lam, W.L., Marra, M., Karsan, A., Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood 117 (2011), 595–607.
283. Subtelny, A.O., Eichhorn, S.W., Chen, G.R., Sive, H., Bartel, D.P., Poly(A)-tail profiling reveals an embryonic switch in translational control. Nature 508 (2014), 66–71.
284. Sugito, N., Ishiguro, H., Kuwabara, Y., Kimura, M., Mitsui, A., Kurehara, H., Ando, T., Mori, R., Takashima, N., Ogawa, R., Fujii, Y., RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin. Cancer Res. 12 (2006), 7322–7328.
285. Sumazin, P., Yang, X., Chiu, H.S., Chung, W.J., Iyer, A., Llobet-Navas, D., Rajbhandari, P., Bansal, M., Guarnieri, P., Silva, J., Califano, A., An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147 (2011), 370–381.
286. Taganov, K.D., Boldin, M.P., Chang, K.J., Baltimore, D., NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U.S.A. 103 (2006), 12481–12486.
287. Takimoto, K., Wakiyama, M., Yokoyama, S., Mammalian GW182 contains multiple Argonaute-binding sites and functions in microRNA-mediated translational repression. RNA 15 (2009), 1078–1089.
288. Tam, W., Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274 (2001), 157–167.
289. Tam, W., Ben-Yehuda, D., Hayward, W.S., bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. 17 (1997), 1490–1502.
290. Tanzer, A., Stadler, P.F., Molecular evolution of a microRNA cluster. J. Mol. Biol. 339 (2004), 327–335.
291. Tay, Y., Zhang, J., Thomson, A.M., Lim, B., Rigoutsos, I., MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455 (2008), 1124–1128.
292. Tay, Y., Kats, L., Salmena, L., Weiss, D., Tan, S.M., Ala, U., Karreth, F., Poliseno, L., Provero, P., Di Cunto, F., Lieberman, J., Rigoutsos, I., Pandolfi, P.P., Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147 (2011), 344–357.
293. Tefferi, A., Lim, K.H., Abdel-Wahab, O., Lasho, T.L., Patel, J., Patnaik, M.M., Hanson, C.A., Pardanani, A., Gilliland, D.G., Levine, R.L., Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 23 (2009), 1343–1345.
294. Teng, G., Hakimpour, P., Landgraf, P., Rice, A., Tuschl, T., Casellas, R., Papavasiliou, F.N., MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28 (2008), 621–629.
295. The C. elegans Sequencing Consortium, Genome sequence of the nematode C. elegans: a platform for investigating biology. Science 282 (1998), 2012–2018.
296. Thomson, D.W., Dinger, M.E., Endogenous microRNA sponges: evidence and controversy. Nat. Rev. Genet. 17 (2016), 272–283.
297. Van Rooij, E., The art of microRNA research. Circ. Res. 108 (2011), 219–234.
298. Vasudevan, S., Posttranscriptional upregulation by microRNAs. Wiley Interdiscip. Rev. RNA 3 (2012), 311–330.
299. Vasudevan, S., Tong, Y., Steitz, J.A., Switching from repression to activation: microRNAs can up-regulate translation. Science 318 (2007), 1931–1934.
300. Vella, M.C., Choi, E.Y., Lin, S.Y., Reinert, K., Slack, F.J., The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3’UTR. Genes Dev. 18 (2004), 132–137.
301. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A., Gocayne, J.D., Amanatides, P., Ballew, R.M., Huson, D.H., Wortman, J.R., Zhang, Q., Kodira, C.D., Zheng, X.H., Chen, L., Skupski, M., Subramanian, G., Thomas, P.D., Zhang, J., Gabor Miklos, G.L., Nelson, C., Broder, S., Clark, A.G., Nadeau, J., Mckusick, V.A., Zinder, N., Levine, A.J., Roberts, R.J., Simon, M., Slayman, C., Hunkapiller, M., Bolanos, R., Delcher, A., Dew, I., Fasulo, D., Flanigan, M., Florea, L., Halpern, A., Hannenhalli, S., Kravitz, S., Levy, S., Mobarry, C., Reinert, K., Remington, K., Abu-Threideh, J., Beasley, E., Biddick, K., Bonazzi, V., Brandon, R., Cargill, M., Chandramouliswaran, I., Charlab, R., Chaturvedi, K., Deng, Z., Di Francesco, V., Dunn, P., Eilbeck, K., Evangelista, C., Gabrielian, A.E., Gan, W., Ge, W., Gong, F., Gu, Z., Guan, P., Heiman, T.J., Higgins, M.E., Ji, R.R., Ke, Z., Ketchum, K.A., Lai, Z., Lei, Y., Li, Z., Li, J., Liang, Y., Lin, X., Lu, F., Merkulov, G.V., Milshina, N., Moore, H.M., Naik, A.K., Narayan, V.A., Neelam, B., Nusskern, D., Rusch, D.B., Salzberg, S., Shao, W., Shue, B., Sun, J., Wang, Z., Wang, A., Wang, X., Wang, J., Wei, M., Wides, R., Xiao, C., Yan, C., et al. The sequence of the human genome. Science 291 (2001), 1304–1351.
302. Ventura, A., Young, A.G., Winslow, M.M., Lintault, L., Meissner, A., Erkeland, S.J., Newman, J., Bronson, R.T., Crowley, D., Stone, J.R., Jaenisch, R., Sharp, P.A., Jacks, T., Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132 (2008), 875–886.
303. Visone, R., Rassenti, L.Z., Veronese, A., Taccioli, C., Costinean, S., Aguda, B.D., Volinia, S., Ferracin, M., Palatini, J., Balatti, V., Alder, H., Negrini, M., Kipps, T.J., Croce, C.M., Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 114 (2009), 3872–3879.
304. Viswanathan, S.R., Daley, G.Q., Gregory, R.I., Selective blockade of microRNA processing by Lin28. Science 320 (2008), 97–100.
305. Wagenaar, T.R., Zabludoff, S., Ahn, S.M., Allerson, C., Arlt, H., Baffa, R., Cao, H., Davis, S., Garcia-Echeverria, C., Gaur, R., Huang, S.M., Jiang, L., Kim, D., Metz-Weidmann, C., Pavlicek, A., Pollard, J., Reeves, J., Rocnik, J.L., Scheidler, S., Shi, C., Sun, F., Tolstykh, T., Weber, W., Winter, C., Yu, E., Yu, Q., Zheng, G., Wiederschain, D., Anti-miR-21 suppresses hepatocellular carcinoma growth via broad transcriptional network deregulation. Mol. Cancer Res. 13 (2015), 1009–1021.
306. Wang, C.H., Lee, D.Y., Deng, Z., Jeyapalan, Z., Lee, S.C., Kahai, S., Lu, W.Y., Zhang, Y., Yang, B.B., MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One, 3, 2008, e2420.
307. Wang, L., Guo, Z.Y., Zhang, R., Xin, B., Chen, R., Zhao, J., Wang, T., Wen, W.H., Jia, L.T., Yao, L.B., Yang, A.G., Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis 34 (2013), 1773–1781.
308. Weber, M.J., New human and mouse microRNA genes found by homology search. FEBS J. 272 (2005), 59–73.
309. Wiestner, A., Tehrani, M., Chiorazzi, M., Wright, G., Gibellini, F., Nakayama, K., Liu, H., Rosenwald, A., Muller-Hermelink, H.K., Ott, G., Chan, W.C., Greiner, T.C., Weisenburger, D.D., Vose, J., Armitage, J.O., Gascoyne, R.D., Connors, J.M., Campo, E., Montserrat, E., Bosch, F., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Fisher, R.I., Grogan, T.M., Miller, T.P., Wilson, W.H., Jaffe, E.S., Staudt, L.M., Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 109 (2007), 4599–4606.
310. Wightman, B., Burglin, T.R., Gatto, J., Arasu, P., Ruvkun, G., Negative regulatory sequences in the lin-14 3’-untranslated region are necessary to generate a temporal switch during Caenorhabditis elegans development. Genes Dev. 5 (1991), 1813–1824.
311. Wightman, B., Ha, I., Ruvkun, G., Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993), 855–862.
312. Wolfrum, C., Shi, S., Jayaprakash, K.N., Jayaraman, M., Wang, G., Pandey, R.K., Rajeev, K.G., Nakayama, T., Charrise, K., Ndungo, E.M., Zimmermann, T., Koteliansky, V., Manoharan, M., Stoffel, M., Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25 (2007), 1149–1157.
313. Woods, K., Thomson, J.M., Hammond, S.M., Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. 282 (2007), 2130–2134.
314. Wurm, A.A., Tenen, D.G., Behre, G., The Janus-faced nature of miR-22 in hematopoiesis: is it an oncogenic tumor suppressor or rather a tumor-suppressive oncogene?. PLoS Genet., 13, 2017, e1006505.
315. Yamanaka, Y., Tagawa, H., Takahashi, N., Watanabe, A., Guo, Y.M., Iwamoto, K., Yamashita, J., Saitoh, H., Kameoka, Y., Shimizu, N., Ichinohasama, R., Sawada, K., Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 114 (2009), 3265–3275.
316. Yang, H., Kong, W., He, L., Zhao, J.J., O'Donnell, J.D., Wang, J., Wenham, R.M., Coppola, D., Kruk, P.A., Nicosia, S.V., Cheng, J.Q., MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res. 68 (2008), 425–433.
317. Yang, J., Li, T., Gao, C., Lv, X., Liu, K., Song, H., Xing, Y., Xi, T., FOXO1 3’UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett. 588 (2014), 3218–3224.
318. Yao, B., Li, S., Lian, S.L., Fritzler, M.J., Chan, E.K., Mapping of Ago2-GW182 functional interactions. Methods Mol. Biol. 725 (2011), 45–62.
319. Yao, Y.D., Sun, T.M., Huang, S.Y., Dou, S., Lin, L., Chen, J.N., Ruan, J.B., Mao, C.Q., Yu, F.Y., Zeng, M.S., Zang, J.Y., Liu, Q., Su, F.X., Zhang, P., Lieberman, J., Wang, J., Song, E., Targeted delivery of PLK1-siRNA by ScFv suppresses Her2 + breast cancer growth and metastasis. Sci. Transl. Med., 4, 2012, 130ra48.
320. Ye, X., Huang, N., Liu, Y., Paroo, Z., Huerta, C., Li, P., Chen, S., Liu, Q., Zhang, H., Structure of C3PO and mechanism of human RISC activation. Nat. Struct. Mol. Biol. 18 (2011), 650–657.
321. Yi, R., Qin, Y., Macara, I.G., Cullen, B.R., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17 (2003), 3011–3016.
322. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., Thomson, J.A., Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007), 1917–1920.
323. Yu, G., Yao, W., Gumireddy, K., Li, A., Wang, J., Xiao, W., Chen, K., Xiao, H., Li, H., Tang, K., Ye, Z., Huang, Q., Xu, H., Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol. Cancer Ther. 13 (2014), 3086–3097.
324. Yuan, J., Nguyen, C.K., Liu, X., Kanellopoulou, C., Muljo, S.A., Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science 335 (2012), 1195–1200.
325. Zaphiropoulos, P.G., Exon skipping and circular RNA formation in transcripts of the human cytochrome P-450 2C18 gene in epidermis and of the rat androgen binding protein gene in testis. Mol. Cell. Biol. 17 (1997), 2985–2993.
326. Zeng, Y., Cullen, B.R., Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res. 32 (2004), 4776–4785.
327. Zhang, G., Xia, S., Tian, H., Liu, Z., Zhou, T., Clinical significance of miR-22 expression in patients with colorectal cancer. Med. Oncol. 29 (2012), 3108–3112.
328. Zhao, J.L., Rao, D.S., Boldin, M.P., Taganov, K.D., O'Connell, R.M., Baltimore, D., NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. U.S.A. 108 (2011), 9184–9189.
329. Zhao, J.L., Rao, D.S., O'Connell, R.M., Garcia-Flores, Y., Baltimore, D., MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice. Elife, 2, 2013, e00537.
330. Zheng, L., Li, X., Gu, Y., Ma, Y., Xi, T., Pseudogene CYP4Z2P 3’UTR promotes angiogenesis in breast cancer. Biochem. Biophys. Res. Commun. 453 (2014), 545–551.
331. Zheng, L., Li, X., Gu, Y., Lv, X., Xi, T., The 3’UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. Breast Cancer Res. Treat. 150 (2015), 105–118.
332. Zhong, X., Li, N., Liang, S., Huang, Q., Coukos, G., Zhang, L., Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J. Biol. Chem. 285 (2010), 41961–41971.
333. Zhou, X., Ruan, J., Wang, G., Zhang, W., Characterization and identification of microRNA core promoters in four model species. PLoS Comput. Biol., 3, 2007, e37.